Kelly MacDonald, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 987 shares at $11.00 ($11K) on 2019-11-08, disclosed to the SEC on 2019-11-12.
Scheduled sale ($11k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 107 | $1K | 10.8% |
| 2 | $11.00 | 880 | $10K | 89.2% |
| Total | $11.00 avg | 987 | $11K | 100% |
| Filing → |
| IRWD | SELL | 2020-11-10 | $31K | — | Filing → |
| IRWD | SELL | 2020-10-13 | $238K | — | Filing → |
| IRWD | SELL | 2020-08-19 | $6K | — | Filing → |